Search - tctmd.com

Displaying 1 - 20 of 24

Sort: Relevancy | Date

SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss

News Conference News TCT 2022

SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss

Michael O'Riordan

September 19, 2022

RADIANCE II Confirms Ultrasound-Based Renal Denervation Lowers BP

News Conference News TCT 2022

RADIANCE II Confirms Ultrasound-Based Renal Denervation Lowers BP

September 18, 2022

Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertension: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial

Presentation TCT 2022

Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertension: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial

Presenter: Deepak Bhatt

September 18, 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

September 07, 2022

RADIOSOUND-HTN Suggests Ultrasound May Be Best for Renal Denervation

News Conference News TCT 2018

RADIOSOUND-HTN Suggests Ultrasound May Be Best for Renal Denervation

September 26, 2018

TCT 2018, Day Four: Bioresorbable Scaffolds, Renal Denervation, Head-to-Head TAVR, INOCA, and . . . That’s a Wrap!

News Opinion Editor's Corner TCT 2018

TCT 2018, Day Four: Bioresorbable Scaffolds, Renal Denervation, Head-to-Head TAVR, INOCA, and . . . That’s a Wrap!

September 25, 2018

Prematurely Halted Pilot Study Snaps Recent Winning Streak for Renal Denervation

News Conference News TCT 2018

Prematurely Halted Pilot Study Snaps Recent Winning Streak for Renal Denervation

September 25, 2018

Untreated Accessory Arteries Dampen Renal Denervation Response: RADIANCE-HTN SOLO

News Conference News TCT 2018

Untreated Accessory Arteries Dampen Renal Denervation Response: RADIANCE-HTN SOLO

September 21, 2018

TCT 83: Long-term (24-Month) Blood Pressure Results of Catheter-Based Renal Artery Denervation SYMPLICITY HTN-3 Randomized Controlled Trial

Presentation TCT 2015

TCT 83: Long-term (24-Month) Blood Pressure Results of Catheter-Based Renal Artery Denervation SYMPLICITY HTN-3 Randomized Controlled Trial

Presenter: Michael A. Weber, Stephen G. Worthley, Deepak L. Bhatt

October 13, 2015

News Conference News TCT 2015

Companies With Innovative Technologies Compete in TCT Shark Tank

October 13, 2015

From SYMPLICITY HTN-3 to Ongoing Renal Denervation Studies: What Answers Can We Expect (and Not Expect) From the Ongoing RDN Studies?

Presentation TCT 2015

From SYMPLICITY HTN-3 to Ongoing Renal Denervation Studies: What Answers Can We Expect (and Not Expect) From the Ongoing RDN Studies?

Presenter: Ori Ben-Yehuda, Ajay J. Kirtane

October 11, 2015

Myths as to Why SYMPLICITY HTN-3 Failed

Presentation TCT 2015

Myths as to Why SYMPLICITY HTN-3 Failed

Presenter: Ajay J. Kirtane, Felix Mahfoud, Darrel P. Francis

October 11, 2015

News Conference News TCT 2015

SYMPLICITY HTN-3 Results Continue to Spur Discussion

October 11, 2015

News Features TCT 2014

Thoughtful Insights at TCT: Tackling Resistant Hypertension, Long SFA Lesions, and Complex Carotid Disease

October 31, 2014

New Insights from SYMPLICITY HTN-3 What I Learned and What I Would Have Done Differently

Presentation TCT 2014

New Insights from SYMPLICITY HTN-3 What I Learned and What I Would Have Done Differently

Presenter: Ajay J. Kirtane, Bram D. Zuckerman, Paul A. Sobotka, Deepak L. Bhatt

September 16, 2014

News Conference News TCT 2014

Experts Debate Future of Renal Denervation

September 16, 2014

News Conference News TCT 2014

SYMPLICITY HTN-3 Substudy Examines BP Response Factors in African Americans

Yael L. Maxwell

September 15, 2014

TCT 405: SYMPLICITY HTN-3: Outcomes in the African-American and NonAfrican American Populations

Presentation TCT 2014

TCT 405: SYMPLICITY HTN-3: Outcomes in the African-American and NonAfrican American Populations

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, John Flack

September 14, 2014

First Deep Dive into SYMPLICITY HTN-3: Primary Results and Updated Analyses

Presentation TCT 2014

First Deep Dive into SYMPLICITY HTN-3: Primary Results and Updated Analyses

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray

September 14, 2014

Second Deep Dive into SYMPLICITY HTN-3: Novel Mechanistic Insights from the Trial

Presentation TCT 2014

Second Deep Dive into SYMPLICITY HTN-3: Novel Mechanistic Insights from the Trial

Presenter: David Kandzari

September 14, 2014

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.